Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Pedro Antonio Regidor, Manopchai Thamkhantho, Chenchit Chayachinda & Santiago Palacios. (2023) Miconazole for the treatment of vulvovaginal candidiasis. In vitro, in vivo and clinical results. Review of the literature. Journal of Obstetrics and Gynaecology 43:1.
Read now
Read now
Tony B. Amos, Leslie Montejano, Paul Juneau & Susan C. Bolge. (2017) Healthcare costs of urinary tract infections and genital mycotic infections among patients with type 2 diabetes mellitus initiated on canagliflozin: a retrospective cohort study. Journal of Medical Economics 20:3, pages 303-313.
Read now
Read now
Neil Skolnik, Harmony Bonnes, Helen Yeh & Arie Katz. (2016) Dapagliflozin in the treatment of patients with type 2 diabetes presenting with high baseline A1C. Postgraduate Medicine 128:4, pages 356-363.
Read now
Read now
Richard F. Arakaki. (2016) Sodium-glucose cotransporter-2 inhibitors and genital and urinary tract infections in type 2 diabetes. Postgraduate Medicine 128:4, pages 409-417.
Read now
Read now
Xing Xu, Gaihong Wang, Tingting Zhou, Lili Chen, Jing Chen & Xu Shen. (2014) Novel approaches to drug discovery for the treatment of type 2 diabetes. Expert Opinion on Drug Discovery 9:9, pages 1047-1058.
Read now
Read now
Articles from other publishers (51)
Danielle J. O’Laughlin & Rozalina G. McCoy. (2023) Diabetes and Vulvovaginal Conditions. Clinical Diabetes 41:3, pages 458-464.
Crossref
Crossref
Jaime A Davidson, Norlela Sukor, Fen‐Lee Hew, Mafauzy Mohamed & Zanariah Hussein. (2022)
Safety of sodium–glucose c
otransporter
2 inhibitors in Asian type 2 diabetes populations
. Journal of Diabetes Investigation 14:2, pages 167-182.
Crossref
Crossref
Leeni Blomberg, Katri Backman, Pirkka V. Kirjavainen, Anne M. Karvonen, Maijakaisa Harju & Leea Keski-Nisula. (2023) Vulvovaginal yeast infections, gestational diabetes and pregnancy outcome. BMC Pregnancy and Childbirth 23:1.
Crossref
Crossref
Atulya Atreja, Sanjay Kalra & Joel Rodriguez-Saldana. 2023. The Diabetes Textbook. The Diabetes Textbook
755
785
.
David Fitchett. 2023. Diabetes and Cardiovascular Disease. Diabetes and Cardiovascular Disease
923
968
.
Jasminka Talapko, Tomislav Meštrović & Ivana Škrlec. (2022) Growing importance of urogenital candidiasis in individuals with diabetes: A narrative review. World Journal of Diabetes 13:10, pages 809-821.
Crossref
Crossref
Serge A. Jabbour, Nasrien E. Ibrahim & Christos P. Argyropoulos. (2022) Physicians’ Considerations and Practice Recommendations Regarding the Use of Sodium-Glucose Cotransporter-2 Inhibitors. Journal of Clinical Medicine 11:20, pages 6051.
Crossref
Crossref
Feifei Zhou, Nannan Du, Lulin Zhou, Chenxi Wang, He Ren & Qiang Sun. (2022) The safety of sotagliflozin in the therapy of diabetes mellitus type 1 and type 2: A meta-analysis of randomized trials. Frontiers in Endocrinology 13.
Crossref
Crossref
HoJin Shin, Sebastian Schneeweiss, Robert J. Glynn & Elisabetta Patorno. (2022) Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium–Glucose Cotransporter-2 Inhibitors Versus Metformin. Annals of Internal Medicine 175:7, pages 927-937.
Crossref
Crossref
Eskedar Getie Mekonnen, Almaz Tefera Gonete & Wubet Worku Takele. (2022) Sexual health-seeking behaviour and associated factors in men with diabetes mellitus attending the northwest Amhara region hospitals, Ethiopia: a cross-sectional study. BMJ Open 12:2, pages e049584.
Crossref
Crossref
Naomi Sugimoto, Yuka Yamagishi & Hiroshige Mikamo. (2022) Effect of Empagliflozin on <i>Candida glabrata</i> Adhesion to Vaginal Epithelial Cells. Medical Mycology Journal 63:2, pages 43-47.
Crossref
Crossref
Roberta Pujia, Samantha Maurotti, Adriana Coppola, Stefano Romeo, Arturo Pujia & Tiziana Montalcini. (2022) The Potential Role of C-peptide in Sexual and Reproductive Functions in Type 1 Diabetes Mellitus: An Update. Current Diabetes Reviews 18:1.
Crossref
Crossref
Marina Pekmezovic, Ann-Kristin Kaune, Sophie Austermeier, Sophia U. J. Hitzler, Selene Mogavero, Hrant Hovhannisyan, Toni Gabaldón, Mark S. Gresnigt & Bernhard Hube. (2021) Human albumin enhances the pathogenic potential of Candida glabrata on vaginal epithelial cells. PLOS Pathogens 17:10, pages e1010037.
Crossref
Crossref
Mohit Chandrashekar, Stuart Philip, Alexander Nesbitt, Andre Joshi & Marlon Perera. (2021) Sodium glucose‐linked transport protein 2 inhibitors: An overview of genitourinary and perioperative implications. International Journal of Urology 28:10, pages 984-990.
Crossref
Crossref
Ji-yun Tian, Yong-gang Yang, Shi Chen, Yong Teng & Xin-zheng Li. (2021) Genetic diversity and molecular epidemiology of Candida albicans from vulvovaginal candidiasis patients. Infection, Genetics and Evolution 92, pages 104893.
Crossref
Crossref
Pedro Vieira-Baptista, Švitrigailė Grincevičienė, Caroline Oliveira, José Fonseca-Moutinho, Facundo Cherey & Colleen Kennedy Stockdale. (2021) The International Society for the Study of Vulvovaginal Disease Vaginal Wet Mount Microscopy Guidelines: How to Perform, Applications, and Interpretation. Journal of Lower Genital Tract Disease 25:2, pages 172-180.
Crossref
Crossref
Janaina de Cássia Orlandi Sardi, Diego Romário Silva, Paula Cristina Anibal, Julianna Joanna Carvalho Moraes de Campos Baldin, Suellen Rodrigues Ramalho, Pedro Luiz Rosalen, Maria Ligia Rodrigues Macedo & José Francisco Hofling. (2021) Vulvovaginal Candidiasis: Epidemiology and Risk Factors, Pathogenesis, Resistance, and New Therapeutic Options. Current Fungal Infection Reports 15:1, pages 32-40.
Crossref
Crossref
Federica Barbagallo, Laura Mongioì, Rossella Cannarella, Sandro La Vignera, Rosita Condorelli & Aldo Calogero. (2020) Sexual Dysfunction in Diabetic Women: An Update on Current Knowledge. Diabetology 1:1, pages 11-21.
Crossref
Crossref
Jaspreet Kalra, Suresh Babu Mangali, Deepika Dasari, Audesh Bhat, Srashti Goyal, Indu Dhar, Dharamrajan Sriram & Arti Dhar. (2019) SGLT1 inhibition boon or bane for diabetes‐associated cardiomyopathy. Fundamental & Clinical Pharmacology 34:2, pages 173-188.
Crossref
Crossref
Vikas S. Sridhar, Habib U. Rahman & David Z.I. Cherney. (2020) What have we learned about renal protection from the cardiovascular outcome trials and observational analyses with SGLT2 inhibitors?. Diabetes, Obesity and Metabolism 22:S1, pages 55-68.
Crossref
Crossref
Mohammad Hassan Halawi, Roudaina Nasser, Wissam Yassine, Hoda Yusef, Jamilah Borjac & Zaher Zeaiter. (2020) First Case of Identification of Candida kefyr and Pichia kluyveri in Lebanese Water. Water, Air, & Soil Pollution 231:3.
Crossref
Crossref
Giovanni Corona, Andrea M. Isidori, Antonio Aversa, Marco Bonomi, Alberto Ferlin, Carlo Foresta, Sandro La Vignera, Mario Maggi, Rosario Pivonello, Linda Vignozzi & Francesco Lombardo. (2019) Male and female sexual dysfunction in diabetic subjects: Focus on new antihyperglycemic drugs. Reviews in Endocrine and Metabolic Disorders 21:1, pages 57-65.
Crossref
Crossref
David Fitchett. (2019) A safety update on sodium glucose co‐transporter 2 inhibitors. Diabetes, Obesity and Metabolism 21:S2, pages 34-42.
Crossref
Crossref
Hiroki Yokoyama, Ami Nagao, Sanae Watanabe & Jun Honjo. (2019) Incidence and risk of vaginal candidiasis associated with sodium-glucose cotransporter 2 inhibitors in real-world practice for women with type 2 diabetes. Journal of Diabetes Investigation 10:2, pages 439-445.
Crossref
Crossref
Célia Rodrigues, Maria Rodrigues & Mariana Henriques. (2019) Candida sp. Infections in Patients with Diabetes Mellitus. Journal of Clinical Medicine 8:1, pages 76.
Crossref
Crossref
Soo Lim. (2019) Safety Issues with Sodium-Glucose Cotransporter 2 Inhibitors: Clinical Considerations. The Journal of Korean Diabetes 20:3, pages 127.
Crossref
Crossref
Sruthi Adimadhyam, Glen T. Schumock, Gregory S. Calip, Daphne E. Smith Marsh, Brian T. Layden & Todd A. Lee. (2018) Increased risk of mycotic infections associated with sodium–glucose co‐transporter 2 inhibitors: a prescription sequence symmetry analysis. British Journal of Clinical Pharmacology 85:1, pages 160-168.
Crossref
Crossref
Atulya Atreja, Sanjay Kalra & Joel Rodriguez-Saldana. 2019. The Diabetes Textbook. The Diabetes Textbook
669
691
.
Gilbert G.G. Donders, Katerina S. Ruban, Gert Bellen & Sivtrigaile Grinceviciene. 2018. Diagnostics to Pathogenomics of Sexually Transmitted Infections. Diagnostics to Pathogenomics of Sexually Transmitted Infections
293
327
.
Mathieu Cauchie, Stefanie Desmet & Katrien Lagrou. (2017) Candida and its dual lifestyle as a commensal and a pathogen. Research in Microbiology 168:9-10, pages 802-810.
Crossref
Crossref
Gregory A. Nichols, Kimberly G. Brodovicz, Teresa M. Kimes, Anouk Déruaz-Luyet & Dorothee B. Bartels. (2017) Prevalence and incidence of urinary tract and genital infections among patients with and without type 2 diabetes. Journal of Diabetes and its Complications 31:11, pages 1587-1591.
Crossref
Crossref
Teresita del Niño Jesús Uribarren-Berrueta, Javier Pineda-Murillo, Arturo Ángel Cortés-Figueroa & Laura Rosio Castañon Olivares. (2017) Candidosis vaginal. Segunda parte:diagnóstico, tratamiento y situación de algunos países latinoamericanos. Revista Médica de Risaralda 23:1.
Crossref
Crossref
Hermann Koepsell. (2017) The Na+-D-glucose cotransporters SGLT1 and SGLT2 are targets for the treatment of diabetes and cancer. Pharmacology & Therapeutics 170, pages 148-165.
Crossref
Crossref
Rhona Johnston, Olalekan Uthman, Ewen Cummins, Christine Clar, Pamela Royle, Jill Colquitt, Bee Kang Tan, Andrew Clegg, Saran Shantikumar, Rachel Court, J Paul O’Hare, David McGrane, Tim Holt & Norman Waugh. (2017) Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluation. Health Technology Assessment 21:2, pages 1-218.
Crossref
Crossref
Julie van Schalkwyk & Mark H. Yudin. (2016) Vulvovaginite : Dépistage et prise en charge de la trichomonase, de la candidose vulvovaginale et de la vaginose bactérienne. Journal of Obstetrics and Gynaecology Canada 38:12, pages S587-S596.
Crossref
Crossref
Sanjay Kalra. (2016) Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review. Cardiology and Therapy 5:2, pages 161-168.
Crossref
Crossref
Erum Malik, Sarah Dennison, Frederick Harris & David Phoenix. (2016) pH Dependent Antimicrobial Peptides and Proteins, Their Mechanisms of Action and Potential as Therapeutic Agents. Pharmaceuticals 9:4, pages 67.
Crossref
Crossref
M. Rizzi & R. Trevisan. (2016) Genitourinary infections in diabetic patients in the new era of diabetes therapy with sodium-glucose cotransporter-2 inhibitors. Nutrition, Metabolism and Cardiovascular Diseases 26:11, pages 963-970.
Crossref
Crossref
Mohammad Salehi, Abdolmajid Ghasemian, Seyyed Khalil Shokouhi Mostafavi, Farshad Nojoomi, Danial Ashiani & Hassan Rajabi Vardanjani. (2016) The Epidemiology of Candida Species Isolated From Urinary Tract Infections. Archives of Clinical Infectious Diseases 11:4.
Crossref
Crossref
Luciene Akimoto-Gunther, Patrícia de Souza Bonfim-Mendonça, Gisele Takahachi, Mary Mayumi T. Irie, Sônia Miyamoto, Márcia Edilaine Lopes Consolaro & Terezinha I. Estivalet Svidzinsk. (2016) Highlights Regarding Host Predisposing Factors to Recurrent Vulvovaginal Candidiasis: Chronic Stress and Reduced Antioxidant Capacity. PLOS ONE 11:7, pages e0158870.
Crossref
Crossref
Pamela Kushner. (2016) Benefits/Risks of Sodium–Glucose Co-Transporter 2 Inhibitor Canagliflozin in Women for the Treatment of Type 2 Diabetes. Women's Health 12:3, pages 379-388.
Crossref
Crossref
Evelyn E. Nash, Brian M. Peters, Elizabeth A. Lilly, Mairi C. Noverr & Paul L. Fidel. (2016) A Murine Model of Candida glabrata Vaginitis Shows No Evidence of an Inflammatory Immunopathogenic Response. PLOS ONE 11:1, pages e0147969.
Crossref
Crossref
Walter Krause & Isaak Effendy. 2016. Anogenitale Hautkrankheiten. Anogenitale Hautkrankheiten
13
54
.
Micheline Moyal-Barracco. 2016. Pruritus. Pruritus
329
342
.
Eva Vivian. (2015) Sodium-Glucose Cotransporter 2 Inhibitors in the Treatment of Type 2 Diabetes Mellitus. The Diabetes Educator 41:1_suppl, pages 5S-18S.
Crossref
Crossref
Cyrus V. Desouza, Namita Gupta & Anery Patel. (2015) Cardiometabolic Effects of a New Class of Antidiabetic Agents. Clinical Therapeutics 37:6, pages 1178-1194.
Crossref
Crossref
Julie van Schalkwyk, Mark H. Yudin, Mark H. Yudin, Victoria Allen, Celine Bouchard, Marc Boucher, Isabelle Boucoiran, Sheila Caddy, Eliana Castillo, V. Logan Kennedy, Deborah M. Money, Kellie Murphy, Gina Ogilvie, Caroline Paquet & Julie van Schalkwyk. (2015) Vulvovaginitis: Screening for and Management of Trichomoniasis, Vulvovaginal Candidiasis, and Bacterial Vaginosis. Journal of Obstetrics and Gynaecology Canada 37:3, pages 266-274.
Crossref
Crossref
O. L. Gazaryan, T. V. Sokolova, A. P. Malyarchuk & V. V. Glad’ko. (2015) Rubromycosis of large folds in outpatients: the characteristic features of the course and therapy optimization. Klinicheskaya dermatologiya i venerologiya 14:6, pages 87.
Crossref
Crossref
Nermin H. Ibrahim, Nahla A. Melake, Ali M. Somily, Azza S. Zakaria, Manal M. Baddour & Amany Z. Mahmoud. (2015) The effect of antifungal combination on transcripts of a subset of drug-resistance genes in clinical isolates of Candida species induced biofilms. Saudi Pharmaceutical Journal 23:1, pages 55-66.
Crossref
Crossref
S. Borelli & S. Lautenschlager. (2014) Differenzialdiagnose und Management der BalanitisDifferential diagnosis and management of balanitis. Der Hautarzt 66:1, pages 6-11.
Crossref
Crossref
Maria Teresa Fernández-Figueras. 2015. Vulvar Pathology. Vulvar Pathology
95
137
.